Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice. [electronic resource]
Producer: 20121016Description: 278-84 p. digitalISSN:- 1499-3872
- Alanine Transaminase -- blood
- Animals
- Apoptosis -- drug effects
- Axin Protein -- metabolism
- Blotting, Western
- Cell Proliferation -- drug effects
- Cyclin D1 -- metabolism
- Disease Models, Animal
- Gene Expression Regulation
- Glycogen Synthase Kinase 3 -- antagonists & inhibitors
- Glycogen Synthase Kinase 3 beta
- Immunohistochemistry
- Indoles -- pharmacology
- Inhibitor of Apoptosis Proteins -- metabolism
- Liver -- blood supply
- Liver Regeneration -- drug effects
- Male
- Maleimides -- pharmacology
- Mice
- Mice, Inbred C57BL
- Phosphorylation
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins -- metabolism
- Proto-Oncogene Proteins c-bcl-2
- Real-Time Polymerase Chain Reaction
- Reperfusion Injury -- enzymology
- Repressor Proteins -- metabolism
- Signal Transduction -- drug effects
- Survivin
- Time Factors
- beta Catenin -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.